These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 12714890)

  • 1. Impact of individual physicians on enrollment of patients into clinical trials.
    Mannel RS; Walker JL; Gould N; Scribner DR; Kamelle S; Tillmanns T; McMeekin DS; Gold MA
    Am J Clin Oncol; 2003 Apr; 26(2):171-3. PubMed ID: 12714890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patient and physician factors associated with participation in cervical and uterine cancer trials: an NRG/GOG247 study.
    Brooks SE; Carter RL; Plaxe SC; Basen-Engquist KM; Rodriguez M; Kauderer J; Walker JL; Myers TK; Drake JG; Havrilesky LJ; Van Le L; Landrum LM; Brown CL
    Gynecol Oncol; 2015 Jul; 138(1):101-8. PubMed ID: 25937529
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characteristics of women with gynecologic cancer who enter clinical trials.
    Luck MB; McIntire M; Blades N; Robinson W
    J Reprod Med; 2005 Jul; 50(7):481-5. PubMed ID: 16130843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with clinical trial screening failures in gynecologic oncology.
    Manders DB; Paulsen A; Richardson DL; Kehoe SM; Miller DS; Lea JS
    Gynecol Oncol; 2014 Sep; 134(3):450-4. PubMed ID: 24992676
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Minority participation in Gynecologic Oncology Group (GOG) Studies.
    Scalici J; Finan MA; Black J; Harmon MD; Nicolson W; Lankes HA; Brady WE; Rocconi RP
    Gynecol Oncol; 2015 Aug; 138(2):441-4. PubMed ID: 26013697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. StatBite: Physicians' role, as reported by patients, and trial enrollment rates.
    J Natl Cancer Inst; 2010 Aug; 102(16):1220. PubMed ID: 20693457
    [No Abstract]   [Full Text] [Related]  

  • 7. Physician-determined patient risk of toxic effects: impact on enrollment and decision making in phase I cancer trials.
    Mick R; Lane N; Daugherty C; Ratain MJ
    J Natl Cancer Inst; 1994 Nov; 86(22):1685-93. PubMed ID: 7966396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancer trial enrollment after state-mandated reimbursement.
    Gross CP; Murthy V; Li Y; Kaluzny AD; Krumholz HM
    J Natl Cancer Inst; 2004 Jul; 96(14):1063-9. PubMed ID: 15265967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patient enrollment onto clinical trials: the role of physician knowledge.
    Gregg JR; Horn L; Davidson MA; Gilbert J
    J Cancer Educ; 2014 Mar; 29(1):74-9. PubMed ID: 24163050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enrollment in clinical trials: institutional factors affecting enrollment in the cardiac arrhythmia suppression trial (CAST).
    Shea S; Bigger JT; Campion J; Fleiss JL; Rolnitzky LM; Schron E; Gorkin L; Handshaw K; Kinney MR; Branyon M
    Control Clin Trials; 1992 Dec; 13(6):466-86. PubMed ID: 1334819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving high cancer control trial enrollment in the community setting: an analysis of the Community Clinical Oncology Program.
    Jacobs SR; Weiner BJ; Minasian LM; Good MJ
    Contemp Clin Trials; 2013 Mar; 34(2):320-5. PubMed ID: 23295315
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Eligibility criteria in randomized phase II and III adjuvant and neoadjuvant breast cancer trials: not a significant barrier to enrollment.
    Filion M; Forget G; Brochu O; Provencher L; Desbiens C; Doyle C; Poirier B; DuRocher M; Camden S; Lemieux J
    Clin Trials; 2012 Oct; 9(5):652-9. PubMed ID: 23060323
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enrollment of patients with lung and colorectal cancers onto clinical trials.
    Fouad MN; Lee JY; Catalano PJ; Vogt TM; Zafar SY; West DW; Simon C; Klabunde CN; Kahn KL; Weeks JC; Kiefe CI
    J Oncol Pract; 2013 Mar; 9(2):e40-7. PubMed ID: 23814523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial discussion, referral, and recruitment: physician, patient, and system factors.
    Kaplan CP; Nápoles AM; Dohan D; Shelley Hwang E; Melisko M; Nickleach D; Quinn JA; Haas J
    Cancer Causes Control; 2013 May; 24(5):979-88. PubMed ID: 23420328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifying barriers associated with enrollment of patients with lung cancer into clinical trials.
    Horn L; Keedy VL; Campbell N; Garcia G; Hayes A; Spencer B; Carbone DP; Sandler A; Johnson DH
    Clin Lung Cancer; 2013 Jan; 14(1):14-8. PubMed ID: 22591607
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An assessment of age and other factors influencing protocol versus alternative treatments for patients with epithelial ovarian cancer referred to member institutions: a Gynecologic Oncology Group study.
    Moore DH; Kauderer JT; Bell J; Curtin JP; Van Le L
    Gynecol Oncol; 2004 Aug; 94(2):368-74. PubMed ID: 15297174
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prospective evaluation of cancer clinical trial accrual patterns: identifying potential barriers to enrollment.
    Lara PN; Higdon R; Lim N; Kwan K; Tanaka M; Lau DH; Wun T; Welborn J; Meyers FJ; Christensen S; O'Donnell R; Richman C; Scudder SA; Tuscano J; Gandara DR; Lam KS
    J Clin Oncol; 2001 Mar; 19(6):1728-33. PubMed ID: 11251003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance and predictors of recruitment success in National Heart, Lung, and Blood Institute's cardiovascular clinical trials.
    Pemberton VL; Evans F; Gulin J; Rosenberg E; Addou E; Burns KM; Gordon DJ; Pearson GD; Kaltman JR
    Clin Trials; 2018 Oct; 15(5):444-451. PubMed ID: 30084662
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Using OncoDoc as a computer-based eligibility screening system to improve accrual onto breast cancer clinical trials.
    Séroussi B; Bouaud J
    Artif Intell Med; 2003; 29(1-2):153-67. PubMed ID: 12957785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer prevention trials and primary care physicians: factors associated with recommending trial enrollment.
    Battaglia TA; Ash A; Prout MN; Freund KM
    Cancer Detect Prev; 2006; 30(1):34-7. PubMed ID: 16476525
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.